Clinical Trials Directory

Trials / Conditions / Stage IIIB Gallbladder Cancer

Stage IIIB Gallbladder Cancer

7 registered clinical trials studyying Stage IIIB Gallbladder Cancer.

StatusTrialSponsorPhase
Active Not RecruitingRecombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or
NCT02495896
University of Southern CaliforniaPhase 1
CompletedGenetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer
NCT02333188
University of ChicagoPhase 1
CompletedTrametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder
NCT02042443
National Cancer Institute (NCI)Phase 2
CompletedADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer
NCT01825603
University of NebraskaPhase 1
WithdrawnSelumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duc
NCT01859182
National Cancer Institute (NCI)Phase 2
CompletedGenotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointest
NCT01643499
University of ChicagoPhase 1
CompletedTriapine and Gemcitabine Hydrochloride in Gallbladder Cancer
NCT00075504
National Cancer Institute (NCI)Phase 2